MHRA-100348-PIP01-21-M01 (update)

Key Facts

Active Substance
Active Substance:
  • botaretigene sparoparvovec
Invented Name
Not yet available
PIP Number MHRA-100348-PIP01-21-M01 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Conditions / Indications
Conditions / Indications:
  • Treatment of retinitis pigmentosa
Route(s) of administration
Route(s) of administration:
  • Ophthalmic use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):botaretigene sparoparvovec.pdf
Published Date 24/06/2024